Inactive Ingredient
Lactose, magnesium stearate
Bm Kali Sulph Tablet
FDA Label NDC 85816-1007
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Bm Private Limited for the product Bm Kali Sulph (NDC 85816-1007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding inactive ingredient, otc - active ingredient, warnings, dosage & administration, indications & usage, otc - purpose, otc - keep out of reach of children, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Active Ingredient
Calc Fluor
Calc Phos
Calc Sulph
Ferr Phos
Kali Mur
Kali Phos
Kali Sulph
Mag Phos
Nat Mur
Nat Phos
Nat Sulph
Silicea
Warnings
Warnings and Storage:
Ask a professional before use if pregnant or breastfeeding, or if you have severe symptoms. Keep away from children. If you have a reaction to this product that is not positive, discontinue use. Store in a cool and dry place.
Dosage & Administration
See individual product directions for use.
Indications & Usage
Temporarily boost cellular nutrition, satisfy mineral imbalances in the body, and stimulate the body's natural healing process
Otc - Purpose
Temporarily boost cellular nutrition, satisfy mineral imbalances in the body, and stimulate the body's natural healing process.
Otc - Keep Out Of Reach Of Children
Warnings:
Keep out of reach of children.
Package Label.Principal Display Panel
box
* Please review the disclaimer below.
